did the fda stop semaglutide approves Ozempic® (semaglutide) as only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease Last week @fda sends out
Description
Semaglutide is not prescribed as a treatment for menstrual irregularities
Human studies suggest that intermittent fasting may help reduce insulin resistance and lower blood sugar levels, thus reducing diabetes risk
The most notable decrease was seen in individuals with obesity (-0.90 kg/m), followed by overweight (-0.70 kg/m) and normal-weight participants (-0.60 kg/m)
Efficacy and safety of lixisenatide as add-on therapy to basal insulin in older adults with type 2 diabetes in the GETGOAL-O study
It took eight days for the pharmacy to actually ship my medication
